StockData
Kiora Pharmaceuticals Inc logo

Kiora Pharmaceuticals Inc (KPRX) stock

KPRXNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as KPHMW
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$0.93−0.05 (-5.30%)

Close on Nov 17, 2026Market cap $4.11MP/E –Yield –

Kiora Pharmaceuticals total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Kiora Pharmaceuticals's total debt was $278.19K at Mar 31, 2021. For fiscal 2020 it was $278.19K.

Annual total debt

PeriodPeriod endValueChange
FY2020Dec 31, 2020$278.19K–
FY2019Dec 31, 2019$0–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2021Mar 31, 2021$278.19K–
Q4 FY2020Dec 31, 2020$278.19K–
Q3 FY2020Sep 30, 2020$278.19K–
Q2 FY2020Jun 30, 2020$278.19K–
Q4 FY2019Dec 31, 2019$0–

More Kiora Pharmaceuticals figures

See a number that looks wrong?